Daiichi Suntory Pharma Co., Ltd.
Records under this name other than patents Daiichi Suntory Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Daiichi Suntory Pharma Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,361,759 | Method for Producing L-Biopterin Formerly held Term ended Term ended Apr 24, 2025 · High confidence | Term ended | Term ended Apr 24, 2025 | High confidence |
| US 8,367,623 | Glycolipid and medicine for autoimmune disease containing the same as active ingredient Formerly held Lapsed on the fee record Ended Feb 5, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | USPTO record |
| US 7,732,583 | Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic intermediates, and synthetic method thereof Formerly held Term ended Term ended Aug 8, 2024 · USPTO record | Term ended | Term ended Aug 8, 2024 | USPTO record |
| US 7,459,551 | Method for Preparing Cyclic Compounds Formerly held Term ended Term ended Mar 25, 2024 · High confidence | Term ended | Term ended Mar 25, 2024 | High confidence |
| US 8,440,628 | Medical Compositions Containing Ghrelin Formerly held Term ended Term ended Sep 17, 2023 · Medium confidence | Term ended | Term ended Sep 17, 2023 | Medium confidence |
| US 7,268,128 | 1,3,5-Trisubstituted-5-Phenyl and 5-Pyridyl Pyrazolopyrimidinone Derivatives Having PDE7 Inhibiting Action Formerly held Term ended Term ended Aug 3, 2023 · High confidence | Term ended | Term ended Aug 3, 2023 | High confidence |
| US 8,518,893 | Medical Compositions Containing Ghrelin Held by another company Term ended Term ended May 21, 2023 · Medium confidence | Term ended | Term ended May 21, 2023 | Medium confidence |
| US 7,138,489 | Method for Producing a Modified Peptide Formerly held Term ended Term ended Apr 10, 2023 · High confidence | Term ended | Term ended Apr 10, 2023 | High confidence |
| US 7,026,293 | Treatment or Prophylaxis of Ischemic Heart Disease Formerly held Term ended Term ended Aug 19, 2021 · High confidence | Term ended | Term ended Aug 19, 2021 | High confidence |
| US 6,703,421 | Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure Formerly held Term ended Term ended Jul 16, 2021 · USPTO record | Term ended | Term ended Jul 16, 2021 | USPTO record |